Market Tracker

10/31 5:32am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

36.15
Data as of Oct 30
 +0.27 / +0.75%
Today’s Change
27.51
Today|||52-Week Range
39.95
+23.80%
Year-to-Date

Today’s Trading

Previous close35.88
Today’s open36.38
Day’s range-- - --
Volume827,181
Average volume (3 months)714,065
Market cap$1.5B
Dividend yield--
Data as of 10/30/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-45.73%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio80.3
Price/Sales3.49
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-1.46-2.03%
CBPOChina Biologic Produ...+3.15+5.58%
NBIXNeurocrine Bioscienc...+0.21+1.18%
PTCTPTC Therapeutics Inc+1.10+2.78%
Data as of 10/30/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts